FindTrial
Sign In

A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19)

The value of Lymphocyte subsets in Coronavirus Disease 2019

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030818
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-01-31
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:none

Sponsors

Department of Critical Care Medicine, The First Affiliated Hospital, Henan Traditional Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 86 Years

Inclusion criteria

Inclusion criteria: Acorrding to Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected Jan 11, 2020.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
ymphocyte subsets;—

Countries

China

Contacts

Public ContactZhengrong Mao

The First Affiliated Hospital, He'nan Traditional Chinese Medicine University

maozhengrong1971@163.com+86 18695808321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026